CVS Health (CVS) Expected to Announce Earnings on Wednesday

CVS Health (NYSE:CVS) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 12th. Analysts expect the company to announce earnings of $0.89 per share and revenue of $96.90 billion for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

CVS Health Trading Up 0.4 %

Shares of CVS Health stock opened at $54.24 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $68.26 billion, a P/E ratio of 13.77, a P/E/G ratio of 0.60 and a beta of 0.61. CVS Health has a 52-week low of $43.56 and a 52-week high of $80.75. The stock’s 50-day simple moving average is $50.79 and its 200 day simple moving average is $55.98.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.90%. CVS Health’s dividend payout ratio is 67.51%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Piper Sandler reduced their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Truist Financial cut their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, TD Cowen boosted their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.